Tumour necrosis factor antagonists
- 1 January 1999
- journal article
- Published by Taylor & Francis in Emerging Drugs
- Vol. 4 (1) , 5-13
- https://doi.org/10.1517/14728214.4.1.5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferationBritish Journal of Pharmacology, 1998
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxideInternational Journal of Immunopharmacology, 1995
- The total costs of drug therapy for rheumatoid arthritisArthritis & Rheumatism, 1995
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?Rheumatology, 1992
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Tumour necrosis factor in synovial exudates.Annals of the Rheumatic Diseases, 1988
- Mediators of InflammationAnnual Review of Immunology, 1983